Table 2 Systematic therapy for HER2-positive or triple-negative breast cancer (voting results)
From: Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus
From: Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus